We showed that inhibiting BCL2 downregulated SOX9 protein and mRNA expression in BCL2‐overexpressing DLBCL, indicating that SOX9 induction was significantly associated with BCL2 rearrangement in the GCB DLBCL subset. Here, BCL2 is linked to diffuse large B-cell lymphoma.